<div id="readability-page-1"><p>WINTON GROUP Ltd purchased a new position in  Maximus, Inc. (NYSE:MMS - Free Report) during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor  purchased 67,945 shares of the health services provider's stock, valued at approximately $6,208,000. WINTON GROUP Ltd owned 0.12% of Maximus at the end of the most recent reporting period.</p><p>A number of other hedge funds have also modified their holdings of the business. Richardson Financial Services Inc. lifted its position in  Maximus by 123.1% during the third quarter. Richardson Financial Services Inc. now owns 348 shares of the health services provider's stock worth $32,000 after buying an additional 192 shares during the period.  Canada Pension Plan Investment Board purchased a new position in  Maximus in the second quarter valued at approximately $35,000.  Cullen Frost Bankers Inc. acquired a new position in shares of  Maximus during the third quarter worth about $38,000.  Parkside Financial Bank &amp; Trust lifted its position in shares of  Maximus by 21.7% during the second quarter. Parkside Financial Bank &amp; Trust now owns 879 shares of the health services provider's stock worth $62,000 after purchasing an additional 157 shares in the last quarter.  Finally, GAMMA Investing LLC grew its stake in shares of  Maximus by 13.9% during the third quarter. GAMMA Investing LLC now owns 1,337 shares of the health services provider's stock valued at $122,000 after acquiring an additional 163 shares in the last quarter. 97.21% of the stock is owned by hedge funds and other institutional investors. </p><h2>Wall Street Analyst Weigh In</h2><p>Several research firms have recently weighed in on MMS. Wall Street Zen downgraded shares of Maximus from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a research report on Monday, February 23rd. Weiss Ratings cut Maximus from a &#34;buy (b)&#34; rating to a &#34;hold (c+)&#34; rating in a research note on Tuesday, February 24th. Finally, Zacks Research upgraded Maximus from a &#34;hold&#34; rating to a &#34;strong-buy&#34; rating in a research report on Tuesday, December 30th. One analyst  has rated the stock with a Strong Buy rating and one  has given a Hold rating to the company's stock. Based on data from MarketBeat, the company  has a consensus rating of &#34;Buy&#34;.</p><p><b>Get Our Latest Report on Maximus</b></p><h2>Maximus Stock Performance</h2><p>Shares of NYSE MMS opened at $77.26 on Tuesday. The company has a market capitalization of $4.21 billion, a P/E ratio of 11.76 and a beta of 0.59. The business's 50-day moving average price is $85.58 and its two-hundred day moving average price is $86.06. Maximus, Inc. has a one year low of $64.68 and a one year high of $100.00. The company has a debt-to-equity ratio of 0.88, a current ratio of 2.34 and a quick ratio of 2.34. </p><p>Maximus (NYSE:MMS - Get Free Report) last issued its quarterly earnings data on Thursday, February 5th. The health services provider reported $1.85 earnings per share for the quarter, beating analysts' consensus estimates of $1.84 by $0.01. Maximus had a return on equity of 25.30% and a net margin of 6.92%.The business had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.37 billion. During the same period last year, the business earned $1.61 EPS. The firm's revenue was down 4.1% compared to the same quarter last year. Maximus has set its FY 2026 guidance at 8.050-8.350 EPS.  Analysts anticipate that  Maximus, Inc. will post 6.15 earnings per share for the current fiscal year. </p><h2>Maximus Increases Dividend</h2><p>The company also recently disclosed a quarterly dividend, which was paid on Monday, March 2nd. Stockholders of record on Friday, February 13th were issued a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a dividend yield of 1.7%. The ex-dividend date of this dividend was Friday, February 13th. This is a boost from Maximus's previous quarterly dividend of $0.30. Maximus's payout ratio is 20.09%. </p><h2>Insiders Place Their Bets</h2><p>In other Maximus news, CEO Bruce Caswell acquired 3,175 shares of the company's stock in a transaction dated Tuesday, February 10th. The stock was bought at an average price of $78.45 per share, for a total transaction of $249,078.75. Following the purchase, the chief executive officer owned 328,013 shares in the company, valued at $25,732,619.85. This represents a 0.98% increase in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CFO David Mutryn purchased 1,000 shares of the stock in a transaction on Monday, February 9th. The stock was bought at an average price of $75.62 per share, for a total transaction of $75,620.00. Following the completion of the transaction, the chief financial officer directly owned 40,037 shares of the company's stock, valued at approximately $3,027,597.94. This trade represents a 2.56% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. 1.80% of the stock is owned by insiders. </p><h2>About Maximus</h2> (Free Report)<p>Maximus, Inc <span>NYSE: MMS<span></span></span> is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children's Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.</p><h2>Featured Stories</h2><ul><li>Five stocks we like better than Maximus</li><li>Buy this Gold Stock Before May 15th, 2026</li><li>The Market Just Split in Two (URGENT)</li><li>J.P. Morgan is betting on this coin</li><li>Central banks just did something they haven’t done since 1967</li><li>Ticker Revealed: Pre-IPO Access to &#34;Next Elon Musk&#34; Company</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1NUw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1NUw"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Maximus Right Now?</h2><p>Before you consider Maximus, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.</p><p>While Maximus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>WINTON GROUP Ltd acquired 67,945 shares of Maximus, Inc. (NYSE:MMS) valued at approximately $6.2 million during Q3, according to a recent SEC filing. Other institutional investors also adjusted their holdings. Maximus's stock has seen mixed ratings from analysts, with a consensus rating of "Buy." The company reported $1.85 EPS for the last quarter, slightly beating estimates, and announced a quarterly dividend increase to $0.33 per share. CEO Bruce Caswell and CFO David Mutryn also made personal stock purchases recently.</p>

67,945 Shares in Maximus, Inc. $MMS Purchased by WINTON GROUP Ltd